Nuclear receptor corepressor-dependent repression of peroxisome-proliferator-activated receptor δ-mediated transactivation

Biochemical Journal

Volumn 363, Issue 1, 2002, Pages 157-165

  Krogsdam, Anne M ^a   Nielsen, Curt A F ^a   Neve, Søren ^a   Holst, Dorte ^a   Helledie, Torben ^a   Thomsen, Bo ^a   Bendixen, Christian ^a   Mandrup, Susanne ^a   Kristiansen, Karsten ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

cAMP; SMRT; Transcriptional repression

Indexed keywords

ASSAYS; HORMONES; PROTEINS; YEAST;

LIGANDS;

BIOCHEMISTRY;

CELL NUCLEUS RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RETINOID X RECEPTOR; THYROID HORMONE RECEPTOR;

ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR INTERACTION; PEPTIDE MAPPING; PEROXISOME; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; CELL LINE; DIMERIZATION; DNA-BINDING PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE TRANSFERASE; HUMANS; LIGANDS; MICE; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN BIOSYNTHESIS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECOMBINANT FUSION PROTEINS; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 0036535037     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/0264-6021:3630157     Document Type: Article

References (52)

1. The nuclear receptor superfamily: The second decade
2. Peroxisome proliferator-activated receptors: From genes to physiology
3. A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport
4. Peroxisome proliferator-activated receptor delta (PPARdelta)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling
5. Expression of peroxisome proliferator-activated receptor PPARdelta promotes induction of PPARgamma and adipocyte differentiation in 3T3C2 fibroblasts
6. Rat PPARdelta contains a CGG triplet repeat and is prominently expressed in the thalamic nuclei
7. Correlation between expression of peroxisome proliterator-activated receptor beta and squamous differentiation in epidermal and tracheobronchial epithelial cells
8. Modulation of keratinocyte gene expression and differentiation by PPAR-selective ligands and tetradecylthioacetic acid
9. Prostacyclin-mediated activation of peroxisome proliferator-activated receptor delta in colorectal cancer
10. Cyclo-oxygenase-2-derived prostacyclin mediates embryo implantation in the mouse via PPARdelta
11. Coactivator and corepressor complexes in nuclear receptor function
12. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors
13. Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-γ
14. The coregulator exchange in transcriptional functions of nuclear receptors
15. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor
16. A transcriptional co-repressor that interacts with nuclear hormone receptors
17. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action
18. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains
19. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (Coup.TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT)
20. Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1
21. Diverse signaling pathways modulate nuclear receptor recruitment of N-CoR and SMRT
22. Identification of nuclear receptor corepressor as a peroxisome proliferator-activated receptor alpha interacting protein
23. A dominant-negative peroxisome proliferator-activated receptor gamma (PPARgamma) mutant is a constitutive repressor and inhibits PPARgamma-mediated adipogenesis
24. A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation
25. The CoRNR motif controls the recruitment of corepressors by nuclear hormone receptors
26. Mechanism of corepressor binding and release from nuclear hormone receptors
27. Molecular determinants of nuclear receptor-corepressor interaction
28. Determinants of CoRNR-dependent repression complex assembly on nuclear hormone receptors
29. A novel role for helix 12 of retinoid X receptor in regulating repression
30. Stoichiometric and steric principles governing repression by nuclear hormone receptors
31. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes
32. Rapid identification of DNA-binding proteins by mass spectrometry
33. Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors
34. Characterization of three RXR genes that mediate the action of 9-cis retinoic acid
35. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor
36. A yeast mating-selection scheme for detection of protein-protein interactions
37. Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases
38. A novel cationic liposome reagent for efficient transfection of mammalian cells
39. The nuclear receptor corepressor (N-CoR) contains three isoleucine motifs (I/LXXII) that serve as receptor interaction domains (IDs)
40. Polarity-specific activities of retinoic acid receptors determined by a co-repressor
41. Recruitment of nuclear receptor corepressor and coactivator to the retinoic acid receptor by retinoid ligands. Influence of DNA-heterodimer interactions
42. Activation of peroxisome proliferator-activated receptors (PPARs) by their ligands and protein kinase A activators
43. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors
44. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region
45. Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors
46. Crystal structure of the ligand binding domain of the human nuclear receptor PPARgamma
47. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation
48. Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators
49. A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor g-activating properties
50. Ligand-induced stabilization of PPARgamma monitored by NMR spectroscopy: Implications for nuclear receptor activation
51. Dynamic stabilization of nuclear receptor ligand binding domains by hormone or corepressor binding